Thwarting Isomerization through Rigidity: A Promising HBED Derivative for the Chelation of Gallium-68
Inorganic Chemistry · 2025
DOI: 10.1021/acs.inorgchem.5c00930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2025. Verfasst von Marianna Tosato und 8 weiteren Autor:innen. Beteiligte Einrichtung: Radiopharmaceutical Chemistry Laboratory, Nuclear Medicine Unit, AUSL-IRCCS Reggio Emilia, 42122 Reggio Emilia, Italy. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Chelating Agents, Edetic Acid, Radiopharmaceuticals. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Azienda Unit? Sanitaria Locale di Reggio Emilia, Ministero della Salute.
Abstract (Originalsprache)
The hexadentate acyclic ligand, N,N'-di(2-hydroxybenzyl)-(1,2-cyclohexanediamine)-N,N'-diacetic acid (HBCD) designed for the chelation of the positron-emitting radiometal 68Ga was developed by replacing the flexible ethylenediamine backbone of its parent ligand, N,N'-di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED), with a more rigid cyclohexane diamine scaffold (DACH). This aims to hinder the formation of multiple isomers upon Ga3+-complexation as observed in HBED-containing molecules, which could affect the in vivo behavior of 68Ga-labeled radiopharmaceuticals. To this end, we report the synthesis of HBCD, a comprehensive investigation of its acid-base behavior, its Ga3+ coordination chemistry, its labeling performances with generator-produced 68Ga, and the stability of the corresponding radioactive complex in physiological media. Our findings confirm that the DACH scaffold promotes the formation of a hexacoordinated single-isomer Ga3+ complex. Although Ga3+-HBCD resulted less thermodynamically stable than Ga3+-HBED, it is by far more stable than the Ga3+ complex formed with the clinical workhorse DOTA chelator. HBCD demonstrated the ability to bind [68Ga]Ga3+ under extremely diluted radiochemical conditions (CL = 10-6 M, 90 °C, pH 4.5 and 7). Notably, [68Ga][Ga(HBCD)]- shows exceptional stability in biological media. These results position HBCD as a highly attractive chelator for the development of next-generation PET radiotracers, effectively addressing the issue of isomerization in its parent ligand HBED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Radiopharmaceutical Chemistry Laboratory, Nuclear Medicine Unit, AUSL-IRCCS Reggio Emilia, 42122 Reggio Emilia, Italy.
- Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
- Department of Chemical Sciences, University of Padova, 35131 Padova, Italy.
ORCID-Profile: Marianna Tosato, Sara Franchi, Erika Ferrari
Förderung
- Azienda Unit? Sanitaria Locale di Reggio Emilia
- Ministero della Salute
Zitieren
APA
Tosato, M., Boniburini, M., Faglioni, F., Genua, F., Mari, M., Storchi, J., Franchi, S., Asti, M., & Ferrari, E. (2025). Thwarting Isomerization through Rigidity: A Promising HBED Derivative for the Chelation of Gallium-68. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.5c00930
Vancouver
Tosato M, Boniburini M, Faglioni F, Genua F, Mari M, Storchi J, et al. Thwarting Isomerization through Rigidity: A Promising HBED Derivative for the Chelation of Gallium-68. Inorganic Chemistry. 2025. doi:10.1021/acs.inorgchem.5c00930
BibTeX
@article{Tosato2025,
author = {Tosato, Marianna and Boniburini, Matteo and Faglioni, Francesco and Genua, Francesco and Mari, Matteo and Storchi, Jennifer and Franchi, Sara and Asti, Mattia and Ferrari, Erika},
title = {Thwarting Isomerization through Rigidity: A Promising HBED Derivative for the Chelation of Gallium-68},
journal = {Inorganic Chemistry},
year = {2025},
doi = {10.1021/acs.inorgchem.5c00930}
}
EUVIMED